Cochrane for Clinicians
Putting Evidence into Practice
Effects of Yoga in Patients with Asthma
Am Fam Physician. 2017 Aug 1;96(3):159-160.
Author disclosure: No relevant financial affiliations.
Does yoga improve quality of life and symptoms in patients with asthma?
Regular yoga improves quality of life as measured on the Asthma Quality of Life Questionnaire (mean difference = 0.57 units on a seven-point scale; 95% confidence interval [CI], 0.37 to 0.77); improves asthma symptoms (standardized mean difference = 0.37; 95% CI, 0.09 to 0.65); and reduces medication use (relative risk [RR] = 5.35; 95% CI, 1.29 to 22.11). However, the high risk of bias and heterogeneity in the included studies limit firm conclusions about the role of yoga in the care of patients with asthma.1 (Strength of Recommendation: B, based on inconsistent or limited-quality patient-oriented evidence.)
Asthma affects 24.6 million Americans.2 In the United States, asthma care costs more than $12.7 billion annually and is associated with absenteeism costs from $6 million to $383 million per state.3 Yoga practice is also prevalent in the United States, with 21 million adult practitioners. Some evidence suggests that yoga may be helpful in improving asthma symptoms and asthma-related quality of life. The authors of this review investigated the effects of yoga on patients with asthma.
This review included 15 randomized controlled trials with 1,048 participants.1 Yoga improved quality of life by a mean 0.57 units on each item of the seven-point scale on the Asthma Quality of Life Questionnaire (95% CI, 0.37 to 0.77), in which a 0.5-unit change is considered significant. Yoga also improved asthma symptoms (standardized mean difference = 0.37; 95% CI, 0.09 to 0.65), although there is no defined minimal clinically important difference for the scale used to assess this. Yoga also reduced medication use (RR = 5.35; 95% CI, 1.29 to 22.11); however, the medications assessed varied among studies, and two studies that were not included in the review demonstrated no differences in medication use.
Yoga had a mixed effect on spirometry parameters. It provided no benefit for forced expiratory volume in one second (FEV1), seemed to improve the peak expiratory flow rate and forced vital capacity (FVC), but had no effect on the FEV1/FVC ratio. Four of the studies in the review looked at adverse effects but did not find enough information to draw conclusions. The authors noted that, despite significant differences in quality-of-life, symptom, and some spirometry parameters, the high risk of bias and heterogeneity in the included studies limited firm conclusions about the role of yoga in the care of patients with asthma.
Clinical guidelines do not mention yoga in the treatment of asthma. Although the European Respiratory Society/American Thoracic Society clinical practice guidelines discuss obesity, tobacco smoke, and air pollution as lifestyle and environmental factors associated with asthma, they do not include yoga as a treatment option.4 The Institute for Clinical Systems Improvement similarly discusses using medications, removing environmental triggers, and raising patient awareness about when asthma symptoms are worsening, but it does not include yoga among its treatment recommendations.5 Despite limited evidence supporting its use, yoga has minimal adverse effects and general health benefits, and it can be considered as an adjunct to traditional pharmacotherapy and environmental risk modification in patients with asthma.
The practice recommendations in this activity are available at http://www.cochrane.org/CD010346.
The views expressed are the author's and do not reflect the official policy or position of the Uniformed Services University of the Health Sciences, the U.S. Army, the Department of Defense, or the U.S. government.
REFERENCESshow all references
1. Yang ZY, Zhong HB, Mao C, et al. Yoga for asthma. Cochrane Database Syst Rev. 2016;(4):CD010346....
2. Centers for Disease Control and Prevention. Most recent asthma data. Updated February 27, 2017. http://www.cdc.gov/asthma/most_recent_data.htm. Accessed June 22, 2017.
3. Trogdon JG, Murphy LB, Khavjou OA, et al. Costs of chronic diseases at the state level: The Chronic Disease Cost Calculator. Prev Chronic Dis. 2015;12: E140.
4. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma [published correction appears in Eur Respir J. 2014;43(4):1216]. Eur Respir J. 2014;43(2):343–373.
5. Bergstrom J, Manney Kurth S, Bruhl E, et al.; Institute for Clinical Systems Improvement. Diagnosis and management of asthma. 2016. https://www.icsi.org/_asset/rsjvnd/Asthma.pdf. Accessed December 14, 2016.
These are summaries of reviews from the Cochrane Library.
This series is coordinated by Corey D. Fogleman, MD, Assistant Medical Editor.
A collection of Cochrane for Clinicians published in AFP is available at https://www.aafp.org/afp/cochrane.
Copyright © 2017 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions
More in AFP
MOST RECENT ISSUE
Jan 15, 2021
Access the latest issue of American Family Physician